News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. As Head Of R&D And Chief Medical Officer



4/15/2014 6:47:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven diseases, today announced the appointment of Karen J. Ferrante, M.D. as head of R&D and chief medical officer. Dr. Ferrante, formerly oncology therapeutic area head for Takeda Pharmaceuticals and the Takeda Cambridge, USA site head, brings nearly 20 years of drug development experience and proven leadership in the pharmaceutical industry to Tokai.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES